Skip to main content
Heavy-duty vehicles contribute 23% of transportation emissions of greenhouse gases and account for almost one-quarter of the fuel consumed annually in the U.S. Credit: Chris Bair/Unsplash

Through a consortium of Department of Energy national laboratories, ORNL scientists are applying their expertise to provide solutions that enable the commercialization of emission-free hydrogen fuel cell technology for heavy-duty

ATOM logo

The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.

The researchers embedded a programmable model into a D-Wave quantum computer chip. Credit: D-Wave

Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.

Oscar Martinez loads a special form capsule into the leak tester for a helium leak test in the packaging facility of the National Transportation Research Center. Credit: Jason Richards/ORNL, U.S. Dept. of Energy

As program manager for the Department of Energy’s Oak Ridge National Laboratory’s Package Testing Program, Oscar Martinez enjoys finding and fixing technical issues.

A Co-Optima research team led by Oak Ridge National Laboratory’s Jim Szybist in collaboration with Argonne, Sandia and the National Renewable Energy Laboratory, created a merit function tool that evaluates six fuel properties and their impact on engine performance, giving the scientific community a guide to quickly evaluate biofuels. Credit: ORNL/U.S. Dept. of Energy

As ORNL’s fuel properties technical lead for the U.S. Department of Energy’s Co-Optimization of Fuel and Engines, or Co-Optima, initiative, Jim Szybist has been on a quest for the past few years to identify the most significant indicators for predicting how a fuel will perform in engines designed for light-duty vehicles such as passenger cars and pickup trucks.

ORNL’s collaboration with Cincinati Children’s Hospital Medical Center will leverage the lab’s expertise in high-performance computing and safe, secure recordkeeping. Credit: Genevieve Martin/Oak Ridge National Laboratory, U.S. Dept. of Energy

There are more than 17 million veterans in the United States, and approximately half rely on the Department of Veterans Affairs for their healthcare.

Jianlin Li employs ORNL’s world-class battery research facility to validate the innovative safety technology. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Soteria Battery Innovation Group has exclusively licensed and optioned a technology developed by Oak Ridge National Laboratory designed to eliminate thermal runaway in lithium ion batteries due to mechanical damage.

ORNL scientists used new techniques to create long lengths of a composite copper-carbon nanotube material with improved properties for use in electric vehicle traction motors. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy

Scientists at Oak Ridge National Laboratory used new techniques to create a composite that increases the electrical current capacity of copper wires, providing a new material that can be scaled for use in ultra-efficient, power-dense electric vehicle traction motors.

Computational biophysicist Ada Sedova is using experiments and high-performance computing to explore the properties of biological systems and predict their form and function, including research to accelerate drug discovery for COVID-19. Photo credit: Jason Richards, Oak Ridge National Laboratory, U.S. Dept. of Energy.

Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology

Omar Demerdash

With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.